Meeting
2020 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy followed by liver resection for patients with metastatic colorectal cancer.
Authors
Rui Jin
Mayo clinic, Rochester, MN
Rui Jin , Zhaohui Jin , Sean P. Cleary , David M. Nagorney , Rory L. Smoot , Robert R. McWilliams , Amit Mahipal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 147)
Abstract #
147
Poster Bd #
G11
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Influence of KRAS status of colorectal cancer liver metastases in patients receiving neoadjuvant chemotherapy including bevacizumab prior liver resection.
First Author: S. Stremitzer
Poster
2021 ASCO Quality Care Symposium
Variable implementation of optimal therapeutic strategies in metastatic colorectal cancer: Reviewing rates of liver resection and triplet chemotherapy across Australian hospitals as potential quality indicators.
First Author: Catherine Dunn
Poster
2018 ASCO Annual Meeting
Impact of the type and modalities of preoperative chemotherapy on the outcome of liver resection for colorectal liver metastases: A LiverMetSurvey study.
First Author: Yuichi Goto
Poster
2013 Gastrointestinal Cancers Symposium
The utility of PET scanning in colorectal cancer liver metastases being considered for surgery.
First Author: Ciara Kelly